Iomervu Injection, Solution
Product Images NDC 0270-7017

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Iomervu (NDC 0270-7017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Iomeprol-structural-formula (Img01)

Chemical structure diagram of iomeprol, the active ingredient in IOMERVU injection. The structure shows a tri-iodinated benzene ring with side chains including hydroxyl, amide, and methyl groups.*

FDA Label Image

Iomervu-ia-iv-350-100ml-internal (Iomervu Ia Iv 350 100ml Internal)

Label for IOMERVU 350 mg Iodine/mL (Iomeprol) injection, a solution for intra-arterial or intravenous use. The 100 mL single dose vial is manufactured by Bracco Diagnostics Inc. The label includes dosage information, storage instructions, and manufacturer details.*

FDA Label Image

Iomervu-ia-iv-350-10x100ml-external (Iomervu Ia Iv 350 10x100ml External)

Label for IOMERVU (iomeprol) injection, 350 mg iodine/mL solution. The label indicates a pack of 10 single-dose 100 mL bottles for intra-arterial or intravenous use only. Manufactured by Bracco Diagnostics Inc. Storage and handling instructions are included, with a note to keep bottles protected from light and not to freeze.*

FDA Label Image

Iomervu-ia-iv-350-10x150ml-external (Iomervu Ia Iv 350 10x150ml External)

Label for IOMERVU (iomeprol) injection, 350 mg iodine/mL, supplied in 150 mL single-dose bottles, 10 bottles per package. The label states it is for intra-arterial or intravenous use only and includes storage instructions. Manufactured by Bracco Diagnostics Inc.*

FDA Label Image

Iomervu-ia-iv-350-10x200ml-external (Iomervu Ia Iv 350 10x200ml External)

Label for IOMERVU (iomeprol) injection, a solution for intra-arterial or intravenous use. This package contains 10 bottles of 200 mL each, with 350 mg iodine per mL concentration. The label includes dosage form, storage instructions, manufacturer Bracco Diagnostics Inc., and cautions about use and light protection.*

FDA Label Image

Iomervu-ia-iv-350-10x50ml-external (Iomervu Ia Iv 350 10x50ml External)

Label for IOMERVU (iomeprol) injection, solution for intra-arterial or intravenous use. Contains 350 mg iodine/mL equivalent to 714 mg iomeprol per mL. Pack includes 10 single-dose vials of 50 mL each. Manufactured for Bracco Diagnostics Inc. with storage instructions and usage precautions noted.*

FDA Label Image

Iomervu-ia-iv-350-150ml-internal (Iomervu Ia Iv 350 150ml Internal)

IOMERVU 350 mg Iodine/mL injection label for a 150 mL single dose bottle. Contains 714 mg iomeprol per mL, indicated for intra-arterial or intravenous use. Label shows dosage instructions, storage conditions (20°C to 25°C), and manufacturer info for Bracco Diagnostics Inc. Includes barcode and lot/expiration date fields.*

FDA Label Image

Iomervu-ia-iv-350-200ml-internal (Iomervu Ia Iv 350 200ml Internal)

Label for IOMERVU (iomeprol) injection, 350 mg iodine/mL in a 200 mL single dose bottle. The label indicates it is for intra-arterial or intravenous use only, with dosage information referencing the prescribing information. Manufactured for Bracco Diagnostics Inc.*

FDA Label Image

Iomervu-ia-iv-350-50ml-internal (Iomervu Ia Iv 350 50ml Internal)

Label for IOMERVU (iomeprol) injection, 350 mg iodine/mL in a 50 mL vial. The label indicates this is a prescription drug for intra-arterial or intravenous use only. It includes storage instructions, manufacturer details (Bracco Diagnostics Inc., Princeton, NJ), and dosage guidance referencing prescribing information. The NDC is 0270-7017-20.*

FDA Label Image

Iomervu-ia-iv-400-100ml-internal (Iomervu Ia Iv 400 100ml Internal)

Label for IOMERVU (iomeprol) injection, 400 mg iodine/mL in a 100 mL single dose bottle. The label states it is for intra-arterial or intravenous use only and includes usage instructions and storage conditions. Manufactured by Bracco Diagnostics Inc. and BIPSO GmbH.*

FDA Label Image

Iomervu-ia-iv-400-10x100ml-external (Iomervu Ia Iv 400 10x100ml External)

Label for IOMERVU (iomeprol) injection, a solution for injection with 400 mg iodine/mL strength. The label indicates a package of 10 bottles, each containing 100 mL. It includes usage instructions specifying intra-arterial or intravenous administration only. Manufactured for Bracco Diagnostics Inc, the label also provides storage conditions and cautions against intrathecal use.*

FDA Label Image

Iomervu-ia-iv-400-10x150ml-external (Iomervu Ia Iv 400 10x150ml External)

IOMERVU (iomeprol) injection label showing 400 mg iodine/mL concentration. The label states 10 bottles of 150 mL each, for intra-arterial or intravenous use only. Manufactured by Bracco Diagnostics Inc., with batch and expiration date fields included. The label advises storage at 20°C to 25°C and not for intrathecal use.*

FDA Label Image

Iomervu-ia-iv-400-10x200ml-external (Iomervu Ia Iv 400 10x200ml External)

Label for IOMERVU (iomeprol) injection, 816 mg/mL, an iodine-based solution for injection. The label states the iodine content as 400 mg/mL, indicates it is for intra-arterial or intravenous use only, and notes storage instructions. Manufactured by Bracco Diagnostics Inc, the label includes NDC 0270-7018-29 and package details as 10 bottles of 200 mL each.*

FDA Label Image

Iomervu-ia-iv-400-10x50ml-external (Iomervu Ia Iv 400 10x50ml External)

Label for IOMERVU (iomeprol) injection, 400 mg iodine/mL. The label specifies 10 vials, 50 mL each, intended for intra-arterial or intravenous use only. Manufacturer is Bracco Diagnostics Inc, with production by BIPSO GmbH, Germany. Additional storage instructions and usage cautions are included.*

FDA Label Image

Iomervu-ia-iv-400-150ml-internal (Iomervu Ia Iv 400 150ml Internal)

Label for IOMERVU (iomeprol) injection, 400 mg iodine/mL, in a 150 mL single-dose bottle. The label specifies use for intra-arterial or intravenous use only. It includes storage instructions, manufacturer details (Bracco Diagnostics Inc.), and notes the solution strength as 816 mg iomeprol per mL providing 400 mg bound iodine. The label warns not for intrathecal use and highlights protection from light and temperature conditions.*

FDA Label Image

Iomervu-ia-iv-400-200ml-internal (Iomervu Ia Iv 400 200ml Internal)

Label for IOMERVU (iomeprol) injection 400 mg iodine/mL in a 200 mL single-dose bottle by Bracco Diagnostics Inc. The label states the product is for intra-arterial or intravenous use only, with storage instructions and a note to discard unused portions. The iodine content per milliliter and pH adjustment information are also shown.*

FDA Label Image

Iomervu-ia-iv-400-50ml-internal (Iomervu Ia Iv 400 50ml Internal)

Label for IOMERVU 400 mg Iomeprol injection, 50 mL solution vial, labeled for intra-arterial or intravenous use only. The text includes dosage, storage instructions (store at 20°C to 25°C, protect from light, do not freeze) and notes single dose vial with discard instructions. Manufactured for Bracco Diagnostics Inc., Princeton, NJ, by BIPSO GmbH, Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.